Literature DB >> 23771508

Acquired neuropathies.

Pierre Lozeron1, Jean-Marc Trocello, Nathalie Kubis.   

Abstract

Acquired neuropathies represent most of the neuropathies encountered in clinical practice. Hundreds of causes have been identified even though up to 41% of patients are still classified as idiopathic (Rajabally and Shah in J Neurol 258:1431-1436, 1). Routine evaluation relies on comprehensive medical history taking, clinical examination, nerve conduction studies and laboratory tests. Other investigations such as nerve biopsy or nerve or muscle imaging are performed in specific settings. This review focuses on recent advances in acquired neuropathies.

Entities:  

Mesh:

Year:  2013        PMID: 23771508     DOI: 10.1007/s00415-013-6994-z

Source DB:  PubMed          Journal:  J Neurol        ISSN: 0340-5354            Impact factor:   4.849


  68 in total

1.  The spectrum of clinicopathological features in pure autonomic neuropathy.

Authors:  Haruki Koike; Rina Hashimoto; Minoru Tomita; Yuichi Kawagashira; Masahiro Iijima; Shigeru Koyano; Takayuki Momoo; Hiroyuki Yuasa; Shigehisa Mitake; Mana Higashihara; Kenichi Kaida; Daisuke Yamamoto; Shin Hisahara; Shun Shimohama; Yoshiharu Nakae; Ken Johkura; Steven Vernino; Gen Sobue
Journal:  J Neurol       Date:  2012-02-24       Impact factor: 4.849

Review 2.  Alcoholic neuropathy: possible mechanisms and future treatment possibilities.

Authors:  Kanwaljit Chopra; Vinod Tiwari
Journal:  Br J Clin Pharmacol       Date:  2012-03       Impact factor: 4.335

3.  Taxane-induced peripheral neuropathy has good long-term prognosis: a 1- to 13-year evaluation.

Authors:  Karima Osmani; Stéphane Vignes; Mouna Aissi; Fatou Wade; Paolo Milani; Bernard I Lévy; Nathalie Kubis
Journal:  J Neurol       Date:  2012-02-17       Impact factor: 4.849

4.  Paraneoplastic neurologic syndrome in the PNS Euronetwork database: a European study from 20 centers.

Authors:  Bruno Giometto; Wolfgang Grisold; Roberta Vitaliani; Francesc Graus; Jérôme Honnorat; Guido Bertolini
Journal:  Arch Neurol       Date:  2010-03

5.  Diagnosis of sporadic transthyretin Val30Met familial amyloid polyneuropathy: a practical analysis.

Authors:  Haruki Koike; Rina Hashimoto; Minoru Tomita; Yuichi Kawagashira; Masahiro Iijima; Fumiaki Tanaka; Gen Sobue
Journal:  Amyloid       Date:  2011-04-05       Impact factor: 7.141

6.  Brachial and lumbar plexuses in chronic inflammatory demyelinating polyradiculoneuropathy: MRI assessment including apparent diffusion coefficient.

Authors:  Yuko Adachi; Noriko Sato; Tomoko Okamoto; Masayuki Sasaki; Hirofumi Komaki; Fumio Yamashita; Jiro Kida; Tomoyuki Takahashi; Hiroshi Matsuda
Journal:  Neuroradiology       Date:  2010-04-20       Impact factor: 2.804

7.  Non-demyelinating, reversible conduction failure in Fisher syndrome and related disorders.

Authors:  Thirugnanam Umapathi; Eyok Yian Tan; Norito Kokubun; Kamal Verma; Nobuhiro Yuki
Journal:  J Neurol Neurosurg Psychiatry       Date:  2012-07-05       Impact factor: 10.154

8.  Modeling nerve conduction criteria for diagnosis of diabetic polyneuropathy.

Authors:  Peter J Dyck; Rickey E Carter; William J Litchy
Journal:  Muscle Nerve       Date:  2011-09       Impact factor: 3.217

9.  Oxidative injury and neuropathy in diabetes and impaired glucose tolerance.

Authors:  James W Russell; Alison Berent-Spillson; Andrea M Vincent; Catherine L Freimann; Kelli A Sullivan; Eva L Feldman
Journal:  Neurobiol Dis       Date:  2008-03-15       Impact factor: 5.996

10.  Guidelines in the management of diabetic nerve pain: clinical utility of pregabalin.

Authors:  Aaron I Vinik; Carolina M Casellini
Journal:  Diabetes Metab Syndr Obes       Date:  2013-02-22       Impact factor: 3.168

View more
  1 in total

Review 1.  Recent advances in the neuroimmunology of cell-surface CNS autoantibody syndromes, Alzheimer's disease, traumatic brain injury and schizophrenia.

Authors:  Ed Needham; Michael S Zandi
Journal:  J Neurol       Date:  2014-09-03       Impact factor: 4.849

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.